title: What is the best plasmatic activity which could be correlated with the antithrombotic effect of heparin and a low molecular weight heparin fragment?
authors.affiliation: Laboratoire d'Hematologie, Faculté de Pharmacie-Place de la Victoire, Bordeaux, France.
authors.forename: C
authors.initials: C
authors.lastname: Doutremepuich
authors.forename: T
authors.initials: T
authors.lastname: Castrioto
authors.forename: O
authors.initials: O
authors.lastname: De Seze
authors.forename: F
authors.initials: F
authors.lastname: Pereira
authors.forename: F
authors.initials: F
authors.lastname: Doutremepuich
authors.forename: M C
authors.initials: MC
authors.lastname: Anne
authors.forename: F
authors.initials: F
authors.lastname: Toulemonde
mesh_terms: D000818:Animals; D005343:Fibrinolytic Agents; D006493:Heparin / Q000494:pharmacology*; D006495:Heparin, Low-Molecular-Weight / Q000494:pharmacology*; D008297:Male; D051381:Rats; D011919:Rats, Inbred Strains; D013927:Thrombosis / Q000517:prevention & control
chemical_list: D005343:Fibrinolytic Agents; D006495:Heparin, Low-Molecular-Weight; D006493:Heparin